A Pilot Study of "OncozeneTM" Microspheres for Intra-arterial Delivery of Doxorubicin
NCT02141906
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Hepatocellular Cancer
Interventions
OTHER:
Oncozene-DEB-TACE
Sponsor
University of Texas Southwestern Medical Center